Top compounds associated with response to OXTR


Feature Type Standardized
Nominal ANOVA
mRNA Irinotecan CCLE pan-cancer AAC -0.1 0.08
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.054 0.08
mRNA Gefitinib GDSC1000 pan-cancer AAC -0.059 0.08
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.061 0.08
mRNA BRD9876 CTRPv2 pan-cancer AAC -0.068 0.08
mRNA S-Trityl-L-cysteine FIMM pan-cancer AAC 0.32 0.08
mRNA SU11274 CTRPv2 pan-cancer AAC -0.063 0.08
mRNA Curcumin CTRPv2 pan-cancer AAC -0.062 0.08
mRNA QL-X-138 GDSC1000 pan-cancer AAC -0.055 0.08
mRNA SR-II-138A CTRPv2 pan-cancer AAC -0.055 0.09
Download CSV